Navigation Links
Bioniche Presents E. coli O157:H7 Vaccine Data to World Buiatrics Congress in Budapest, Hungary
Date:7/10/2008

cultural exhibits provide many possible routes of transmission for E. coli. Direct animal contact is the obvious route, but contact with contaminated products (e.g., sawdust, shavings, soiled clothing or shoes) can also lead to human infection.

The E. coli O157:H7 cattle vaccine will be manufactured in the Bioniche production facility in Belleville, Ontario, Canada where a two-year, $25 million expansion is taking place, supported by the Ontario and Canadian governments. Vaccine supply will be limited during this manufacturing expansion period.

About the E. coli O157:H7 Cattle Vaccine

This vaccine received international recognition in September, 2007 by the Animal Pharm Industry Excellence Awards as the best new veterinary product for livestock globally. The vaccine has been developed by a strategic alliance formed in 2000 between the University of British Columbia (UBC), the Alberta Research Council (ARC), the University of Saskatchewan's Vaccine & Infectious Disease Organization (VIDO), and Bioniche, which holds the rights for worldwide commercialization of the vaccine. The vaccine prevents the E. coli O157:H7 bacteria from attaching to the intestines of vaccinated cattle, thereby reducing their reproduction within the animal, and reducing the amount of bacteria that can be released through cattle manure in the environment. More than 30,000 cattle have been involved in clinical testing of the vaccine over the past five years.

About Bioniche Life Sciences Inc.

Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide. The fully-integrated company employs approximately 200 skilled personnel and has three operating divisions: Human Health, Animal Health, and Food Safety. The Company's primary goal is to develop proprietary cancer therapies supported by r
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Bioniche Hosts Veterinarians and Food Industry Reps at Two-Day E. coli O157:H7 Vaccine Conference
2. Bioniche Secures Final Financing to Scale-up E. coli O157:H7 Vaccine Production
3. Bioniche Presents E. coli O157:H7 Vaccine Data to International Congress of Medical Microbiology in Serbia
4. Bioniche Presents Pre-Clinical Research at Two International Conferences
5. Bioniche Updates re: Mycobacterial Cell Wall Technology Platform
6. Bioniche Reports Fiscal 2008 Third Quarter
7. Bioniche Appoints U.S. President of Food Safety
8. Bioniche Reports the Passing of its Board Chair
9. Bioniche Converts a Portion of its Debt to Equity
10. Bioniche Receives Fast Track Designation For First-Line Bladder Cancer Therapy
11. Bioniche Pharma Chooses TrackWise for its Deviation Control Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... (PRWEB) March 02, 2015 In light ... of anticoagulant Xarelto (rivaroxaban) tablets, Ford & ... may be helpful for future users, but may come ... injuries from taking the drug. The FDA has now ... under Adverse Reactions on Xarelto's label. The term “cytolytic ...
(Date:3/2/2015)... March 02, 2015 ProvidaStaff ... for its educational healthcare division to EDU Healthcare ... healthcare services to school systems and students nationwide. , ... to school districts throughout the country,” said Angela M. ... be a better organization and the introduction of EDU ...
(Date:3/1/2015)... To help healthcare organizations ... practices compliantly and profitably, MDreferralPRO and Vericle ... The interoperability between a strategic referral management ... management system is necessary for a healthcare ... referral management and development solution relies on ...
(Date:3/1/2015)... 2015 Women’s Excellence now offers ... (OAB) symptoms, such as a strong need to urinate with ... medication (anticholinergic) does not work well enough or cannot be ... another approach to targeting the source of OAB, the bladder ... and bladder muscle, blocking the signals that trigger OAB. ...
(Date:3/1/2015)... March 01, 2015 A federal ... http://www.consumerinjurylawyers.com/wright-profemur-hip-replacement ) scheduled to go to trial in ... a witness to provide testimony regarding the role ... of the Profemur device, Bernstein Liebhard LLP comments. ... Court, Northern District of Iowa on February 25th, ...
Breaking Medicine News(10 mins):Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 2Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 3Health News:Ford & Associates Nationwide Legal Services, A.P.C., Comments on Xarelto Lawsuits Upon FDA Revisions 4Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 2Health News:ProvidaStaff Announces New Name Change to EDU Healthcare for Its Educational Healthcare Division 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 2Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 4Health News:Women's Excellence Now Offers BOTOX For Overactive Bladder Treatment 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3
... may help reduce unnecessary surgeries in women of reproductive ... study appearing in the February issue of the journal ... of preoperative CT over the past decade, along with ... in negative appendectomies among women 45 years and younger," ...
... WASHINGTON , Jan. 25 Detroit -area ... in a Detroit -area home health care fraud scheme, announced ... U.S. Attorney for the Eastern District of Michigan Barbara L. McQuade; ... Field Office; and Special Agent in Charge Lamont Pugh III of ...
... , , "Was John Brown,s raid on Harpers ... a hero or a villain?" Randall Terry , WICHITA, ... by Randall Terry , Director, Operation Rescue Insurrecta Nex. , Statement ... or condemn Scott Roeder,s actions. That decision will soon rest ...
... "America,s health care problems did not change when the ... need Congress to act on Health Care Reform now", insists Dr. ... focus on the economy and jobs is necessary and proper, however ... health care reform will bring to all Americans.   We must ...
... , Jan. 25 January is almost over and ... spirit of the Holidays, the Phoenix Quest Center is offering the ... development.  This course is a great opportunity to help participants start ... as offering them valuable skills in dealing with social conflicts of ...
... , PHILADELPHIA , Jan. 25 ... defects in humans, affecting 8 per 1000 live births ... early infancy. Increasing numbers of survivors combined with developmental ... led to a growing identification of neurobehavioral symptoms in ...
Cached Medicine News:Health News:Preoperative CT useful for younger women with suspected appendicitis 2Health News:Physical Therapist Pleads Guilty in Connection with Detroit Home Health Care Fraud Scheme 2Health News:Physical Therapist Pleads Guilty in Connection with Detroit Home Health Care Fraud Scheme 3Health News:Scott Roeder Trial: Randall Terry, Operation Rescue Founder and Insurrecta Nex Members to Attend Trial in Wichita 2Health News:National Medical Association Urges Congress to Deliver on Health Care 2Health News:60-Day Free Community Confidence Building and Self-Defense Training 2Health News:Special Bypass Procedure Used During Infant Heart Surgery Does Not Impair Later Neurological Outcomes in Children 2Health News:Special Bypass Procedure Used During Infant Heart Surgery Does Not Impair Later Neurological Outcomes in Children 3
(Date:3/2/2015)... March 2, 2015 Edison ... announces the initiation of full coverage of Abzena  ... by Edison,s pharma & biotech analysts Christian ... include: Abzena offers a range of ... safer and more effective biological products. Antitope (immunogenicity ...
(Date:3/2/2015)... 2, 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... of the t:slim® and t:flex™ Insulin Pumps, today announced ... of common stock have exercised their option to purchase ... a price to the public of $11.50 per share. ... expected to be $64.8 million, after deducting underwriting discounts ...
(Date:3/2/2015)... 2, 2015 For the past 15 years, there has ... in the U.S. alone (U.S. Census Bureau 2012). Of course, not ... benders BUT there are quite a few where the car occupants ... can obstruct the seatbelt release button or occupant injury. ... serious accidents in their lifetime but may still be "lucky" enough ...
Breaking Medicine Technology:Edison Initiates Coverage on Abzena 2Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 3New SuperVizor, an Automobile Escape Tool, Ensures the Safety of Drivers and Passengers on the Road 2
... Split Splint reduces PIP joint or DIP joint ... to put on. Soft gel-lining cushions injured fingers ... begin earlier for faster, more successful therapy results. ... and at night to maintain gains in motion. ...
... restore full PIP joint or DIP joint ... to arthritic changes. Unparalleled in comfort and ... finger to prevent slipping and allows for ... Sold in packages of 5 and boxes ...
One splint does it all....
... of minor knee pain like arthritis, tendonitis ... with the motion of the knee, applying ... tendon and assisting in the relief of ... with high density foam padding molds itself ...
Medicine Products: